Product Description
Adverse reactions of cefradine were mild, with an incidence of about 6%. Nausea, vomiting, diarrhea, upper abdominal discomfort and other gastrointestinal reactions are common. The incidence of drug eruption is 1% ~ 3%, pseudomembranous enteritis, eosinophilia, peripheral blood image leukocytes and neutropenia are seen in individual patients. A few patients may have temporary increase of blood urea nitrogen, transient increase of serum aminotransferase and serum alkaline phosphatase.
1, mainly rash, drug fever, etc., occasionally anaphylactic shock.
2, digestive system: nausea, vomiting, diarrhea and abdominal discomfort and other symptoms are more common, occasionally see pseudomembranous enteritis.
3, blood system: a small number of patients after medication can appear eosinophilia, white blood cell total or neutrophilia.
4. Nephrotoxicity: A small number of patients may have temporary increases in urea nitrogen after medication, but no serious nephrotoxicity has been reported.
5. Hepatotoxicity: A few patients may have transient elevation of alkaline phosphatase, serum alanine aminotransferase and aspartate aminotransferase after medication.
6. Others: The pain at the intramuscular injection site of cefradine was more obvious, and phlebitis was reported after intravenous injection.
Audited Supplier 
){kind=link}